QLGN - Qualigen Therapeutics, Inc.
3.12
-0.120 -3.846%
Share volume: 6,788
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.24
-0.12
-0.04%
Summary score
18%
Profitability
0%
Dept financing
50%
Liquidity
55%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
-491.59%
Return on invested capital
0%
Total debt ratio
132.1%
Debt ratio change over timeo
0%
Current Ratio
1.35%
Quick Ratio
1.87%
Cash Position Ratio
0.84%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
213.92%
Debt ratio change over timeo
0%
Current Ratio
0.43%
Quick Ratio
0.39%
Cash Position Ratio
0.14%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
451.04%
Debt ratio change over time
0%
Current Ratio
0.22%
Quick Ratio
0%
Cash Position Ratio
0.02%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | QLGN | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 18.83% | 17.34% | 0% |
| Return on assets | 0% | 4.14% | 8.21% | 0% |
| Return on sales | -491.59% | 27.93% | 41.18% | 0% |
| Return on invested capital | 0% | 9.79% | -219.55% | 0% |
| Profitability | 0% | 80% | 73% | 0% |
| Total debt ratio | 132.1% | 82.52% | 55.88% | 0% |
| Debt ratio change over time | 0% | -13.08% | -0.73% | 0% |
| Dept financing | 50% | 16% | 11% | 0% |
| Current Ratio | 0.43% | 1.13% | 0% | 0% |
| Quick Ratio | 0.39% | 0.87% | 0% | 0% |
| Cash Position Ratio | 0.14% | 0.12% | 0% | 0% |
| Liquididy | 75% | 40% | 42% | 0% |
| Short-term ratios | QLGN | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 13.31% | 0% | 0% |
| Return on assets | 0% | 4.46% | 0% | 0% |
| Return on sales | 0% | 29.96% | 0% | 0% |
| Return on invested capital | 0% | 10.68% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 213.92% | 81.12% | 0% | 0% |
| Debt ratio change over time | 0% | -58.72% | 0% | 0% |
| Dept financing | 50% | 9% | 0% | 0% |
| Current Ratio | 0.43% | 1.13% | 0% | 0% |
| Quick Ratio | 0.39% | 0.87% | 0% | 0% |
| Cash Position Ratio | 0.14% | 0.12% | 0% | 0% |
| Liquididy | 46% | 71% | 0% | 0% |